Raunak Shrestha, PhD

About Raunak Shrestha, PhD

Raunak Shrestha, PhD, With an exceptional h-index of 15 and a recent h-index of 15 (since 2020), a distinguished researcher at University of California, San Francisco, specializes in the field of Bioinformatics, Epigenomics, Cancer Genomics, Prostate Cancer.

His recent articles reflect a diverse array of research interests and contributions to the field:

Abstract LB196: An atlas of accessible chromatin in advanced prostate cancer

Somatostatin receptor 1 (SSTR1) expression as a potential predictive biomarker for response to androgen receptor signaling inhibitor (ARSI) therapy in metastatic …

Association of a prostate cancer gastrointestinal transcriptional phenotype as found in clinical mCRPC samples with response to AR-targeted therapy.

Abstract A062: Alternative promoter usage is linked to transcriptional and epigenetic alterations during prostate cancer progression

Abstract PR003: Convergent evolution in DNA repair-deficient mCRPC in response to targeted therapy

Abstract B066: Genome-wide CRISPR screens identify PTGES3 as a druggable AR modulator

Abstract A029: Whole genome and transcriptome analysis of paired metastatic biopsies identified resistance mechanisms in castration-resistant prostate cancer

The genomic and epigenomic landscape of double-negative metastatic prostate cancer

Raunak Shrestha, PhD Information

University

Position

(UCSF)

Citations(all)

2513

Citations(since 2020)

2363

Cited By

908

hIndex(all)

15

hIndex(since 2020)

15

i10Index(all)

21

i10Index(since 2020)

19

Email

University Profile Page

Google Scholar

Raunak Shrestha, PhD Skills & Research Interests

Bioinformatics

Epigenomics

Cancer Genomics

Prostate Cancer

Top articles of Raunak Shrestha, PhD

Title

Journal

Author(s)

Publication Date

Abstract LB196: An atlas of accessible chromatin in advanced prostate cancer

Cancer Research

Raunak Shrestha

Lisa N Chesner

Meng Zhang

Stanley Zhou

Adam Foye

...

2024/4/1

Somatostatin receptor 1 (SSTR1) expression as a potential predictive biomarker for response to androgen receptor signaling inhibitor (ARSI) therapy in metastatic …

Xiaolin Zhu

Daniel J Vis

Martin Sjöström

Raunak Shrestha

Jeroen Kneppers

...

2024/2/1

Association of a prostate cancer gastrointestinal transcriptional phenotype as found in clinical mCRPC samples with response to AR-targeted therapy.

Aishwarya Subramanian

Meng Zhang

Marina Nasrin Sharifi

Thaidy Moreno Rodriguez

Eric Feng

...

2024/2/1

Abstract A062: Alternative promoter usage is linked to transcriptional and epigenetic alterations during prostate cancer progression

Cancer Research

Meng Zhang

Martin Sjöström

Raunak Shrestha

Arian Lundberg

Thaidy Moreno-Rodriguez

...

2023/6/2

Abstract PR003: Convergent evolution in DNA repair-deficient mCRPC in response to targeted therapy

Cancer Research

Thaidy Moreno

Meng Zhang

Arian Lundberg

Raunak Shrestha

Martin Sjöström

...

2023/6/2

Abstract B066: Genome-wide CRISPR screens identify PTGES3 as a druggable AR modulator

Cancer Research

Haolong Li

James E Melnyk

Becky Xu Hua Fu

Siyu Feng

Martin Sjöström

...

2023/6/2

Abstract A029: Whole genome and transcriptome analysis of paired metastatic biopsies identified resistance mechanisms in castration-resistant prostate cancer

Cancer Research

Xiaolin Zhu

Daniël Vis

Martin Sjöström

Raunak Shrestha

Jeroen Kneppers

...

2023/6/2

The genomic and epigenomic landscape of double-negative metastatic prostate cancer

Cancer Research

Arian Lundberg

Meng Zhang

Rahul Aggarwal

Haolong Li

Li Zhang

...

2023/8/15

Beyond Reconstruction: What Leads to Satisfaction in Post-Disaster Recovery?

Journal of Happiness Studies

Ratna K Shrestha

Raunak Shrestha

Sara Shneiderman

Jeevan Baniya

2023/4

Abstract B012: Genomic and epigenomic drivers of double-negative metastatic prostate cancer

Cancer Research

Arian Lundberg

Meng Zhang

Rahul R Aggarwal

Haolong Li

Li Zhang

...

2023/6/2

The 5-hydroxymethylcytosine landscape of prostate cancer

Cancer research

Martin Sjöström

Shuang G Zhao

Samuel Levy

Meng Zhang

Yuhong Ning

...

2022/11/2

Predicting cancer drug TARGETS-treatment response generalized elastic-neT signatures

NPJ genomic medicine

Nicholas R Rydzewski

Erik Peterson

Joshua M Lang

Menggang Yu

S Laura Chang

...

2021/9/21

An integrated functional and clinical genomics approach reveals genes driving aggressive metastatic prostate cancer

Nature Communications

Rajdeep Das

Martin Sjöström

Raunak Shrestha

Christopher Yogodzinski

Emily A Egusa

...

2021/7/29

Multiomics characterization of low-grade serous ovarian carcinoma identifies potential biomarkers of MEK inhibitor sensitivity and therapeutic vulnerability

Cancer Research

Raunak Shrestha

Marta Llaurado Fernandez

Amy Dawson

Joshua Hoenisch

Stanislav Volik

...

2021/1/13

Y-box binding protein-1 is crucial in acquired drug resistance development in metastatic clear-cell renal cell carcinoma

Journal of Experimental & Clinical Cancer Research

Ninadh M D’Costa

Matthew R Lowerison

Peter A Raven

Zheng Tan

Morgan E Roberts

...

2020/12

Pan-cancer analysis of whole genomes

Nature

2020/2/6

Identification of Conserved Evolutionary Trajectories in Tumors

Bioinformatics

Ermin Hodzic

Raunak Shrestha

Salem Malikic

Colin C Collins

Kevin Litchfield

...

2020/7

Pathway and network analysis of more than 2500 whole cancer genomes

Nature Communications

Matthew A Reyna

David Haan

Marta Paczkowska

Lieven PC Verbeke

Miguel Vazquez

...

2020/2/5

Well-Differentiated Papillary Mesothelioma of the Peritoneum is Genetically Distinct from Malignant Mesothelioma

Korean Journal of Pathology

Seyda Erdogan

Arbil Acikalin

Handan Zeren

Gulfılız Gonlusen

Suzan Zorludemir

...

2014/6

Group segmentation and heterogeneity in the choice of cooking fuels in post-earthquake Nepal

arXiv preprint arXiv:2005.09616

Ratna K Shrestha

Raunak Shrestha

2020/5/16

See List of Professors in Raunak Shrestha, PhD University(University of California, San Francisco)

Co-Authors

academic-engine